Product Images Meclizine Hydrochloride

This is a description of medication for vertigo called Meclizine HCI. Each tablet contains 12.5 mg of mecizine dihydrochloride, equivalent to 1053 mg of meclizine free base. The usual dosage should be determined by a physician, and the tablets should be stored in a tight, light-resistant container between 20°C and 25°C (68°F and 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F), according to USP Controlled Room Temperature. The medication should be kept away from children. Additionally, it provides information on product ID and expiration information.*

This text describes the storage and dispensing instructions for Meclizine HCI Tablets, USP 25 mg, and its usual dosage for the treatment of vertigo, with additional information such as the NDC and expiration date. It also reminds to keep medication away from children.*

This is a description for Meclizine HCI, a medication used to treat vertigo. It has 25 mg to 100 mg dosage taken in divided doses daily with the actual dosage depending on the patient's clinical response. Each tablet contains 50 mg meclizine dihydrochloride equivalent to 42.14 mg of meclizine free base. It is stored between 20°C and 25°C (68°F and 77°F) and is usually dispensed in tight, light-resistant containers. Children should be kept away from this medication. The accompanying prescribing information should be referred to for the usual dosage. This product is Manufactured for Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328. The expiration date and lot number are also provided.*